Innate Lymphoid Cells: 10 Years On.
By É. Vivier, D. Artis, M. Colonna, A. Diefenbach, J. D. Di Santo, G. Eberl, S. Koyasu, R. Locksley, Andrew N. J. McKenzie, R. Mebius and 2 more. Cell, 2018
1,825 citations recorded by the source corpus.
Innate lymphoid cells (ILCs) are lymphocytes that do not express the type of diversified antigen receptors expressed on T cells and B cells. ILCs are largely tissue-resident cells and are deeply integrated into the fabric of tissues. The discovery and investigation of ILCs over the past decade has changed our perception of immune regulation and how the immune system contributes to the maintenance of tissue homeostasis. We now know that cytokine-producing ILCs contribute to multiple immune pathways by, for example, sustaining appropriate immune responses to commensals and pathogens at mucosal barriers, potentiating adaptive immunity, and regulating tissue inflammation. Critically, the biology of ILCs also extends beyond classical immunology to metabolic homeostasis, tissue remodeling, and dialog with the nervous system. The last 10 years have also contributed to our greater understanding of the transcriptional networks that regulate lymphocyte commitment and delineation. This, in conjunction with the recent advances in our understanding of the influence of local tissue microenvironments on the plasticity and function of ILCs, has led to a re-evaluation of their existing categorization. In this review, we distill the advances in ILC biology over the past decade to refine the nomenclature of ILCs and highlight the importance of ILCs in tissue homeostasis, morphogenesis, metabolism, repair, and regeneration.
Subfields: Immunology, Surgery
View Paper: https://www.semanticscholar.org/paper/89d078eb88973f92713ff9b0e15bd63941ea2ce9
Citations in the corpus
- Immunology of COVID-19: Current State of the Science (2020, neutral): “Relevance for Helper ILCs in SARS-CoV-2 Infection No studies, to date, have reported ILC1, ILC2, or ILC3 functions in SARS-CoV-2 infection.”